tag gilead 
pharmaphorum
OCTOBER 29, 2021
Hopefully a new standard of care for the aggressive disease, according to partners Gilead Sciences and Merck & Co. Gilead is sponsoring the new study to see if adding Trodelvy can be an alternative chemo when added to Keytruda in the first-line treatment of advanced TNBC, in the hope of moving the ADC up the treatment pathway.
pharmaphorum
JANUARY 21, 2022
This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 5, 2021
TIGIT is very much among the front runners however, and Roche is being closely pursued by other drug developers including Merck & Co with MK-7684 and Gilead/Arcus, which are also in mid-stage testing, as well as iTeos Therapeutics and Mereo BioPharma. Meanwhile, drugs targeting TIM-3, LAG3, VISTA and STING also coming through development.
XTalks
MARCH 22, 2023
In the span of two years, there was a flurry of these types of David-and-Goliath acquisitions, including Johnson & Johnson buying Actelion , Gilead Sciences gaining Kite Pharma and Takeda Pharmaceutical acquiring Shire. In 2019, BMS acquired Celgene in a $74 billion deal.
The Pharma Data
MAY 4, 2021
billion, primarily driven by Pfizer CentreOne, Pfizer’s contract manufacturing operation, reflecting sales of legacy Upjohn products to Viatris (4) and remdesivir to Gilead Sciences Inc., Hospital products, which grew 10% operationally to $2.3 down 7%, which reflects relatively stable U.S. View source version on businesswire.com : [link].
Expert insights. Personalized for you.
52 
Let's personalize your content